{"count": 2, "results": [{"_id": "40957477", "pmid": 40957477, "title": "The eternal struggle between titans: Fecal microbiota transplant (FMT) versus metformin in type 2 diabetes (T2D) gut dysmotility.", "journal": "J Adv Res", "authors": ["La Sala L", "Carlini V", "Macas-Granizo MB", "Trabucchi E", "Pontiroli AE", "Berra C", "Naselli A", "D'Anzeo M", "Porta A", "Martin Delgado J", "Vianello E", "Dozio E", "Corsi Romanelli M", "Drago L"], "date": "2025-09-14T00:00:00Z", "doi": "10.1016/j.jare.2025.09.021", "meta_date_publication": "2025 Sep 14", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50262.9, "text_hl": "The eternal struggle between titans: Fecal microbiota transplant (FMT) versus @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type 2 diabetes@@@ (@DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@T2D@@@) @<m>DISEASE_Esophageal_Motility_Disorders</m> @DISEASE_MESH:D015154 @@@gut dysmotility@@@.", "citations": {"NLM": "La Sala L, Carlini V, Macas-Granizo MB, Trabucchi E, Pontiroli AE, Berra C, Naselli A, D'Anzeo M, Porta A, Martin Delgado J, Vianello E, Dozio E, Corsi Romanelli M, Drago L. The eternal struggle between titans: Fecal microbiota transplant (FMT) versus metformin in type 2 diabetes (T2D) gut dysmotility. J Adv Res. 2025 Sep 14;():. PMID: 40957477", "BibTeX": "@article{40957477, title={The eternal struggle between titans: Fecal microbiota transplant (FMT) versus metformin in type 2 diabetes (T2D) gut dysmotility.}, author={La Sala L and Carlini V and Macas-Granizo MB and Trabucchi E and Pontiroli AE and Berra C and Naselli A and D'Anzeo M and Porta A and Martin Delgado J and Vianello E and Dozio E and Corsi Romanelli M and Drago L}, journal={J Adv Res}}"}}, {"_id": "23020253", "pmid": 23020253, "title": "Effects of saxagliptin added to sub-maximal doses of metformin compared with uptitration of metformin in type 2 diabetes: the PROMPT study.", "journal": "Curr Med Res Opin", "authors": ["Hermans MP", "Delibasi T", "Farmer I", "Lohm L", "Maheux P", "Piatti P", "Malvolti E", "Jörgens S", "Charbonnel B"], "date": "2012-10-01T00:00:00Z", "doi": "10.1185/03007995.2012.735646", "meta_date_publication": "2012 Oct", "meta_volume": "28", "meta_issue": "10", "meta_pages": "1635-45", "score": 50055.0, "text_hl": "Effects of @CHEMICAL_saxagliptin @CHEMICAL_MESH:C502994 @@@saxagliptin@@@ added to sub-maximal doses of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ compared with uptitration of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type 2 diabetes@@@: the PROMPT study.", "citations": {"NLM": "Hermans MP, Delibasi T, Farmer I, Lohm L, Maheux P, Piatti P, Malvolti E, Jörgens S, Charbonnel B. Effects of saxagliptin added to sub-maximal doses of metformin compared with uptitration of metformin in type 2 diabetes: the PROMPT study. Curr Med Res Opin. 2012 Oct;28(10):1635-45. PMID: 23020253", "BibTeX": "@article{23020253, title={Effects of saxagliptin added to sub-maximal doses of metformin compared with uptitration of metformin in type 2 diabetes: the PROMPT study.}, author={Hermans MP and Delibasi T and Farmer I and Lohm L and Maheux P and Piatti P and Malvolti E and Jörgens S and Charbonnel B}, journal={Curr Med Res Opin}, volume={28}, number={10}, pages={1635-45}}"}}]}